CAST and beyond. Implications of the cardiac arrhythmia suppression trials. By the Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
出版信息
Eur Heart J. 1990 Mar;11(3):194-9.
PMID:2108031
Abstract
摘要
相似文献
1
2
CAST and beyond. Implications of the Cardiac Arrhythmia Suppression Trial. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.心脏心律失常抑制试验（CAST）及其他。欧洲心脏病学会心律失常工作组特别工作组报告。
Circulation. 1990 Mar;81(3):1123-7. doi: 10.1161/01.cir.81.3.1123.
3
Lessons from the cardiac arrhythmia suppression trial.心律失常抑制试验的经验教训。
BMJ. 1989 Sep 30;299(6703):805-6. doi: 10.1136/bmj.299.6703.805.
4
The events surrounding the removal of encainide and flecainide from the Cardiac Arrhythmia Suppression Trial (CAST) and why CAST is continuing with moricizine.
J Am Coll Cardiol. 1990 Jan;15(1):243-5. doi: 10.1016/0735-1097(90)90209-8.
5
Implications of the Cardiac Arrhythmia Suppression Trial for antiarrhythmic drug treatment.心律失常抑制试验对抗心律失常药物治疗的启示
Am J Cardiol. 1990 Feb 20;65(8):3D-10D; discussion 68D-71D. doi: 10.1016/0002-9149(90)91410-8.
6
Flecainide and CAST.
Lancet. 1989 Aug 26;2(8661):481-2.
7
Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS.恩卡胺、氟卡胺、丙咪嗪和莫雷西嗪对急性心肌梗死后一年内室性心律失常的影响：CAPS研究
Am J Cardiol. 1988 Mar 1;61(8):501-9. doi: 10.1016/0002-9149(88)90754-0.
8
Comparisons of efficacy and tolerance of moricizine with other antiarrhythmic agents in the treatment of chronic ventricular arrhythmias.莫雷西嗪与其他抗心律失常药物治疗慢性室性心律失常的疗效及耐受性比较。
Am J Cardiol. 1990 Feb 20;65(8):32D-40D. doi: 10.1016/0002-9149(90)91415-3.
9
Drugs for cardiac arrhythmias: new warning.
Med Lett Drugs Ther. 1989 May 19;31(792):48.
10
The cardiac arrhythmia suppression trial (CAST).心律失常抑制试验（CAST）
N Engl J Med. 1989 Aug 10;321(6):386-8. doi: 10.1056/NEJM198908103210608.
Zotero 插件